KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $2.2 billion.

  • Resmed's Total Liabilities rose 1557.81% to $2.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 1557.81%. This contributed to the annual value of $2.2 billion for FY2025, which is 986.78% up from last year.
  • As of Q4 2025, Resmed's Total Liabilities stood at $2.2 billion, which was up 1557.81% from $2.2 billion recorded in Q3 2025.
  • Resmed's Total Liabilities' 5-year high stood at $2.9 billion during Q4 2022, with a 5-year trough of $1.6 billion in Q4 2021.
  • Over the past 5 years, Resmed's median Total Liabilities value was $2.0 billion (recorded in 2024), while the average stood at $2.1 billion.
  • As far as peak fluctuations go, Resmed's Total Liabilities surged by 8490.55% in 2022, and later crashed by 2339.82% in 2024.
  • Over the past 5 years, Resmed's Total Liabilities (Quarter) stood at $1.6 billion in 2021, then surged by 84.91% to $2.9 billion in 2022, then fell by 17.52% to $2.4 billion in 2023, then fell by 22.07% to $1.9 billion in 2024, then increased by 15.58% to $2.2 billion in 2025.
  • Its Total Liabilities stands at $2.2 billion for Q4 2025, versus $2.2 billion for Q3 2025 and $2.2 billion for Q2 2025.